{"altmetric_id":4694832,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Otsuka Pharmaceutical Co., Ltd."],"first_seen_on":"2015-10-28T16:08:34+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1328895263,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01451164?term=OPC-34712&recr=Open&no_unk=Y&rank=6"],"nct_id":"NCT01451164","pubdate":"2011-10-11T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia","type":"clinical_trial_study_record"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":4435446,"mean":4.8079004221261,"rank":983569,"this_scored_higher_than_pct":64,"this_scored_higher_than":2880906,"rank_type":"exact","sample_size":4435446,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":76473,"mean":5.392995684695,"rank":13865,"this_scored_higher_than_pct":81,"this_scored_higher_than":62118,"rank_type":"exact","sample_size":76473,"percentile":81},"this_journal":{"total_number_of_other_articles":8610,"mean":2.8259916366593,"rank":2057,"this_scored_higher_than_pct":85,"this_scored_higher_than":7404,"rank_type":"exact","sample_size":8610,"percentile":85},"similar_age_this_journal_3m":{"total_number_of_other_articles":239,"mean":1.8031512605042,"rank":23,"this_scored_higher_than_pct":87,"this_scored_higher_than":210,"rank_type":"exact","sample_size":239,"percentile":87}}},"demographics":[],"counts":{"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:34671528"],"posts_count":1}},"posts":{"wikipedia":[{"title":"Brexpiprazole","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=476147615#altmetric_citation_38","license":"public","citation_ids":[4694832],"posted_on":"2012-02-10T17:34:23+00:00","summary":"Brexpiprazole ( ; also called OPC-34712) is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD).Although it failed Stag","page_url":"http:\/\/en.wikipedia.org\/?curid=34671528","wiki_lang":"en","author":{"name":"Jmdault","url":"http:\/\/en.wikipedia.org\/wiki\/User:Jmdault"}}]}}